The investment blueprint intended to build the South Korean conglomerate's lead in next-generation technologies. Samsung Electronics and affiliates like Samsung Biologics aim to lead research and spending in areas from telecommunications and robotics to corporate acquisitions.

The envisioned spending includes expenditures outlined previously, such as Samsung Electronics' long-term goal of investing $151 billion through 2030 to delve deeper into advanced chipmaking.

The announcement comes days after Samsung scion Jay Y. Lee walked out of jail where he was serving a sentence on graft charges. The release was just months ahead of South Korea's presidential election and there is nothing suspicious about that at all.

In the months after his imprisonment, a supply crunch in the global semiconductor industry and Samsung’s role in facilitating a Covid-19 vaccine deal with the US fanned calls from business leaders and politicians to free Lee. Still, activists have criticized the decision, saying it was proof of preferential treatment for the powerful tycoon class known as chaebols.